Efficacy and safety of platelet-rich plasma for acute achilles tendon injury: a meta-analysis
Journal Title: Chinese Journal of Blood Transfusion - Year 2024, Vol 37, Issue 4
Abstract
Objective To evaluate the clinical efficacy and safety of platelet-rich plasma(PRP) in acute achilles tendon injury by meta-analysis. Methods Literature on clinical randomized controlled trial of PRP in the treatment of acute achilles tendon injury from Wanfang database, CNKI, VIP database, The Chinese Biological Literature Database, The Chinese Clinical Trials Registry, PubMed, Embase, Cochrane and The US Clinical Trials Registry as of August 2023 were retrieved. The control group received conventional treatment for acute achilles tendon injury, while PRP treatment group received additional PRP treatment. The primary outcome measure was visual analogue pain scale, and the secondary outcome measures were the achilles tendon fracture score, maximum heel rise height, calf circumference and ankle range of motion. The quality of the literature was assessed using the Cochrane manual, and a meta-analysis of qualified literature was performed using RevMan 5.3 software. Results Seven articles were finally included, involving 421 patients with acute achilles tendon injury, including 212 patients in the PRP treatment group, and 209 patients in the conventional treatment group. The results of meta-analysis showed that there was no difference between the conventional treatment group and the PRP treatment group in terms of the visual analogue pain scale(SMD=-0.44, 95%CI: -0.94~0.06, P>0.05), calf circumference (MD=1.14, 95% CI: -1.56-3.84, P>0.05), ankle joint toe flexion range of motion (SMD=1.85, 95%CI: -1.38-5.09, P>0.05), ankle dorsiflexion range of motion(SMD=2.61, 95%CI: -0.95-6.17, P>0.05), achilles tendon fracture score (MD=-5.60, 95%CI: -15.36-4.16, P>0.05) and the maximum heel rise height (MD=-2.48, 95%CI: -5.30-0.33, P>0.05). And there was no difference in the incidence of adverse reactions between the two groups (X2=2. 455, P>0.05). Conclusion PRP injection for acute achilles tendon injury does not improve the biomechanical and clinical outcomes of patients, and the use of PRP does not increase the occurrence of adverse reactions.
Authors and Affiliations
Yali DU, Kaifei FU, Yanju WANG, Rong ZHANG, Chengwen CUI, Xuebing JIANG
Research on the performance evaluation model of national key special projects of blood center
[Objective] To establish performance evaluation indicators and provide a scientific and reliable method for the performance evaluation for national key special projects of blood center. [Methods] Through literature revie...
Establishment and identification of a human megakaryocytic cell line with low Ley expression
Objective To establish a stable human megakaryocytic cell line with low expression of Ley antigen to further study the role of Ley on activation of platelets. Methods The expression level of the Ley antigen in a human me...
Retrospective analysis and prevention strategies of blood-borne occupational exposure in Beijing Red Cross Blood Center from 2010 to 2021
Objective To understand the occupational exposure of blood center staff during blood collection and supply, analyze the influencing factors, explore preventive measures and improve the self-protection awareness of staff,...
Potential value of differential expression of CDC42 gene in adult and umbilical cord blood reticulocytes
Objective To explore critical regulatory genes in the hemoglobin switch process by analyzing transcriptomic data from the GSE6236, GSE17639 and GSE35102 datasets. Methods The mRNA expression profiles of the three dataset...
Voluntary blood donation intention of students in middle vocational school in Jinhua and its influencing factors
Objective To explore the intention of voluntary blood donation in students from a middle vocational school in Jinhua and its influencing factors. Methods A total of 400 students were enrolled from a middle vocational sch...